Paul P. Shields
Chief Operating Officer at Enteris BioPharma, Inc.
Profile
Paul P.
Shields is currently the Chief Operating Officer at Enteris BioPharma, Inc. Prior to this, he worked as the Vice President-Manufacturing Operations at Unigene Laboratories, Inc. Shields holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from the University of Michigan.
Paul P. Shields active positions
| Companies | Position | Start |
|---|---|---|
Enteris BioPharma, Inc.
 Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Chief Operating Officer | - |
Former positions of Paul P. Shields
| Companies | Position | End |
|---|---|---|
| UNIGENE LABORATORIES INC | Corporate Officer/Principal | - |
Training of Paul P. Shields
| University of Pennsylvania | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Unigene Laboratories, Inc.
 Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Health Technology |
- Stock Market
- Insiders
- Paul P. Shields
